ZAS Corporation Successfully Launches Celltrion Biosimilars in Bangladesh
We are proud to announce the successful launch of Celltrion’s biosimilar products in Bangladesh, marking a significant milestone in our […]
We are proud to announce the successful launch of Celltrion’s biosimilar products in Bangladesh, marking a significant milestone in our […]
Dhaka, Bangladesh – ZAS Corporation Ltd., a leading pharmaceutical company with a strong focus on oncology, recently held a transformative
ZAS Corporation, in collaboration with the Bangladesh Society of Critical Care Medicine (BSCCM), recently organized a scientific seminar focused on
ZAS Corporation is proud to announce the successful launch of Polymyxin B, a groundbreaking antibiotic from our Critical Care division.
ZAS Corporation Ltd. has pledged its support to the 4th International Scientific Conference of Bangladesh Perinatal Society, reinforcing its dedication
In a groundbreaking collaboration, the Bangladesh Endocrine Society (BES) joined forces with medical experts to conduct a Continuing Medical Education
In a promising stride towards combating respiratory infections, ZAS Corporation Ltd. joined hands with the Bangladesh Lung Foundation to pioneer
In a thrilling event marking a milestone in healthcare innovation, ZAS Group has unveiled five cutting-edge platforms, bringing healthcare services
Morinaga Research Centre, Japan, joins hands with esteemed KOL Doctors from Bangladesh to pioneer groundbreaking collaborations, aimed at revolutionizing healthcare
The Philippine business tour proved to be a uniquely successful experience, highlighted by productive meetings and promising partnerships. Enthusiastically anticipating